Literature DB >> 27739438

MicroRNA profiling of low-grade glial and glioneuronal tumors shows an independent role for cluster 14q32.31 member miR-487b.

Heather Marion Ames1, Ming Yuan1, Maria Adelita Vizcaíno1,2, Wayne Yu3, Fausto J Rodriguez1,3.   

Abstract

Low-grade (WHO I-II) gliomas and glioneuronal tumors represent the most frequent primary tumors of the central nervous system in children. They often have a good prognosis following total resection, however they can create many neurological complications due to mass effect, and may be difficult to resect depending on anatomic location. MicroRNAs have been identified as molecular regulators of protein expression/translation that can repress multiple mRNAs concurrently through base pairing, and have an important role in cancer, including brain tumors. Using the NanoString digital counting system, we analyzed the expression levels of 800 microRNAs in nine low-grade glial and glioneuronal tumor types (n=45). A set of 61 of these microRNAs were differentially expressed in tumors compared with the brain, and several showed levels varying by tumor type. The expression differences were more accentuated in subependymal giant cell astrocytoma, compared with other groups, and demonstrated the highest degree of microRNA repression validated by RT-PCR, including miR-129-2-3p, miR-219-5p, miR-338-3p, miR-487b, miR-885-5p, and miR-323a-3p. Conversely, miR-4488 and miR-1246 were overexpressed in dysembryoplastic neuroepithelial tumors compared with the brain and other tumors. The cluster 14q32.31 member miR-487b was variably under-expressed in pediatric glioma lines compared with human neural stem cells. Overexpression of miR-487b in a pediatric glioma cell line (KNS42) using lentiviral vectors led to a decrease in colony formation in soft agar (30%) (P<0.05), and decreased expression of known predicted targets PROM1 and Nestin (but not WNT5A). miR-487b overexpression had no significant effect on cell growth, proliferation, sensitivity to temozolomide, migration, or invasion. In summary, microRNA regulation appears to have a role in the biology of glial and glioneuronal tumor subtypes, a finding that deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27739438      PMCID: PMC5288128          DOI: 10.1038/modpathol.2016.177

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  63 in total

1.  miR-487b promotes human umbilical vein endothelial cell proliferation, migration, invasion and tube formation through regulating THBS1.

Authors:  Nianping Feng; Zhengfei Wang; Zhuo Zhang; Xijun He; Chunlai Wang; Liming Zhang
Journal:  Neurosci Lett       Date:  2015-02-04       Impact factor: 3.046

2.  p53 downregulates Down syndrome-associated DYRK1A through miR-1246.

Authors:  Yu Zhang; Jun-Ming Liao; Shelya X Zeng; Hua Lu
Journal:  EMBO Rep       Date:  2011-06-03       Impact factor: 8.807

3.  MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.

Authors:  Nian-Sheng Lai; Qing-Sheng Dong; Hao Ding; Zeng-Li Miao; Yu-Chang Lin
Journal:  J Clin Neurosci       Date:  2013-09-11       Impact factor: 1.961

4.  Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.

Authors:  Gwangil Kim; Hee-Jung An; Mi-Jung Lee; Ji-Ye Song; Ju-Yeon Jeong; Ji-Hyun Lee; Hye-Cheol Jeong
Journal:  Lung Cancer       Date:  2015-11-17       Impact factor: 5.705

5.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

6.  Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.

Authors:  David T W Jones; Barbara Hutter; Natalie Jäger; Andrey Korshunov; Marcel Kool; Hans-Jörg Warnatz; Thomas Zichner; Sally R Lambert; Marina Ryzhova; Dong Anh Khuong Quang; Adam M Fontebasso; Adrian M Stütz; Sonja Hutter; Marc Zuckermann; Dominik Sturm; Jan Gronych; Bärbel Lasitschka; Sabine Schmidt; Huriye Seker-Cin; Hendrik Witt; Marc Sultan; Meryem Ralser; Paul A Northcott; Volker Hovestadt; Sebastian Bender; Elke Pfaff; Sebastian Stark; Damien Faury; Jeremy Schwartzentruber; Jacek Majewski; Ursula D Weber; Marc Zapatka; Benjamin Raeder; Matthias Schlesner; Catherine L Worth; Cynthia C Bartholomae; Christof von Kalle; Charles D Imbusch; Sylwester Radomski; Chris Lawerenz; Peter van Sluis; Jan Koster; Richard Volckmann; Rogier Versteeg; Hans Lehrach; Camelia Monoranu; Beate Winkler; Andreas Unterberg; Christel Herold-Mende; Till Milde; Andreas E Kulozik; Martin Ebinger; Martin U Schuhmann; Yoon-Jae Cho; Scott L Pomeroy; Andreas von Deimling; Olaf Witt; Michael D Taylor; Stephan Wolf; Matthias A Karajannis; Charles G Eberhart; Wolfram Scheurlen; Martin Hasselblatt; Keith L Ligon; Mark W Kieran; Jan O Korbel; Marie-Laure Yaspo; Benedikt Brors; Jörg Felsberg; Guido Reifenberger; V Peter Collins; Nada Jabado; Roland Eils; Peter Lichter; Stefan M Pfister
Journal:  Nat Genet       Date:  2013-06-30       Impact factor: 38.330

7.  Nonrandom chromosomal gains in pilocytic astrocytomas of childhood.

Authors:  F V White; D C Anthony; E J Yunis; N J Tarbell; R M Scott; D E Schofield
Journal:  Hum Pathol       Date:  1995-09       Impact factor: 3.466

8.  Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.

Authors:  C-H Gattolliat; L Thomas; S A Ciafrè; G Meurice; G Le Teuff; B Job; C Richon; V Combaret; P Dessen; D Valteau-Couanet; E May; P Busson; S Douc-Rasy; J Bénard
Journal:  Br J Cancer       Date:  2011-10-04       Impact factor: 7.640

9.  Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.

Authors:  N Takeshita; I Hoshino; M Mori; Y Akutsu; N Hanari; Y Yoneyama; N Ikeda; Y Isozaki; T Maruyama; N Akanuma; A Komatsu; M Jitsukawa; H Matsubara
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

10.  A critical evaluation of microRNA biomarkers in non-neoplastic disease.

Authors:  Baqer A Haider; Alexander S Baras; Matthew N McCall; Joshua A Hertel; Toby C Cornish; Marc K Halushka
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more
  16 in total

1.  miR-217-casein kinase-2 cross talk regulates ERK activation in ganglioglioma.

Authors:  Atreye Majumdar; Fahim Ahmad; Touseef Sheikh; Reshma Bhagat; Pankaj Pathak; Shanker Datt Joshi; Pankaj Seth; Vivek Tandon; Manjari Tripathi; P Saratchandra; Chitra Sarkar; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2017-08-25       Impact factor: 4.599

2.  INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma.

Authors:  Heather M Ames; Lisa M Rooper; John J Laterra; Charles G Eberhart; Fausto J Rodriguez
Journal:  J Neuropathol Exp Neurol       Date:  2018-05-01       Impact factor: 3.685

3.  RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.

Authors:  Rui-Chao Chai; Yi-Ming Li; Ke-Nan Zhang; Yu-Zhou Chang; Yu-Qing Liu; Zheng Zhao; Zhi-Liang Wang; Yuan-Hao Chang; Guan-Zhang Li; Kuan-Yu Wang; Fan Wu; Yong-Zhi Wang
Journal:  JCI Insight       Date:  2019-08-13

4.  MicroRNA Alterations in Induced Pluripotent Stem Cell-Derived Neurons from Bipolar Disorder Patients: Pathways Involved in Neuronal Differentiation, Axon Guidance, and Plasticity.

Authors:  Monica Bame; Melvin G McInnis; K Sue O'Shea
Journal:  Stem Cells Dev       Date:  2020-06-17       Impact factor: 3.272

Review 5.  Ubiquitous Neural Cell Adhesion Molecule (NCAM): Potential Mechanism and Valorisation in Cancer Pathophysiology, Drug Targeting and Molecular Transductions.

Authors:  S Sowparani; P Mahalakshmi; J Pushpa Sweety; Arul Prakash Francis; U M Dhanalekshmi; N Selvasudha
Journal:  Mol Neurobiol       Date:  2022-07-12       Impact factor: 5.682

6.  MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression.

Authors:  Giuseppina Catanzaro; Zein Mersini Besharat; Andrea Carai; Natalie Jäger; Elena Splendiani; Carole Colin; Agnese Po; Martina Chiacchiarini; Anna Citarella; Francesca Gianno; Antonella Cacchione; Evelina Miele; Francesca Diomedi Camassei; Marco Gessi; Luca Massimi; Franco Locatelli; David T W Jones; Dominique Figarella-Branger; Stefan M Pfister; Angela Mastronuzzi; Felice Giangaspero; Elisabetta Ferretti
Journal:  Biomark Res       Date:  2022-06-17

Review 7.  Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.

Authors:  Alti Dayakar; Kumar D Shanmukha; Suresh K Kalangi
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.742

8.  MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma.

Authors:  Ming Yuan; Ana Cristina A L Da Silva; Antje Arnold; Laurence Okeke; Heather Ames; Lina S Correa-Cerro; M Adelita Vizcaino; Cheng-Ying Ho; Charles G Eberhart; Fausto J Rodriguez
Journal:  Sci Rep       Date:  2018-08-21       Impact factor: 4.379

9.  miR-487b-3p Suppresses the Proliferation and Differentiation of Myoblasts by Targeting IRS1 in Skeletal Muscle Myogenesis.

Authors:  Jian Wang; Jiaoyan Tan; Qi Qi; Lingzhi Yang; Yanhong Wang; Chunlei Zhang; Linyong Hu; Hong Chen; Xingtang Fang
Journal:  Int J Biol Sci       Date:  2018-05-12       Impact factor: 6.580

10.  Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas.

Authors:  Anupam Kumar; Subhashree Nayak; Pankaj Pathak; Suvendu Purkait; Prit Benny Malgulawar; Mehar Chand Sharma; Vaishali Suri; Arijit Mukhopadhyay; Ashish Suri; Chitra Sarkar
Journal:  J Neurooncol       Date:  2018-06-21       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.